Why is AbbVie Inc. stock down today?

April 13, 2026

AbbVie Inc.

ABBV · NYQ · USD

$207.94

▼ 4.46 (2.10%)

vs. prev. close $212.4

Last updated Apr 10, 2026 20:00

Intraday Chart — 5-min intervals

📊

AI Summary

ABBV · less than a minute ago

cached

AbbVie Inc. slides 2.10% amid market weakness

AbbVie Inc. (ABBV) is selling off, at $207. 94 — down 2. 10% from yesterday's close of $212. 40. Today's move appears driven by recent headlines, including "AbbVie Signs Global Pain Drug Licensing Deal With Haisco" and "Haisco Enters into Exclusive License Agreement with AbbVie to Develop Novel Medicines for Pain". News sentiment around ABBV is leaning mixed.

The broader market is under pressure (S&P 500: -0. 1%, Nasdaq: +0. 4%, Dow Jones: -0. 6%, Shanghai: +0. 6%, Hang Seng: -1. 0%). Past performance does not guarantee future results.

Key Factors

1AbbVie Signs Global Pain Drug Licensing Deal With Haisco

2Haisco Enters into Exclusive License Agreement with AbbVie to Develop Novel Medicines for Pain

3AbbVie Showcases Late‑Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx (ELAHERE®) in Platinum‑Sensitive Ovarian Cancer (PSOC) at SGO 2026

4🌐 Broad market: S&P 500: -0.1%, Nasdaq: +0.4%, Dow Jones: -0.6%, Shanghai: +0.6%, Hang Seng: -1.0%

Auto-generated analysis · Not financial advice

less than a minute ago

📰Recent News

8 neutral

⚠️ Disclaimer: The information on this page is for informational purposes only and does not constitute financial advice. AI-generated summaries may be inaccurate. Always conduct your own research and consult a licensed financial advisor before making any investment decisions. Past performance is not indicative of future results.

🌐Market ContextRisk-Off 📉

S&P 500

-0.11%

Nasdaq

+0.35%

Dow Jones

-0.56%

Shanghai

+0.56%

Hang Seng

-1.04%

Nikkei 225

-0.74%

FTSE 100

-0.54%

Nifty 50

-0.95%

DAX

-0.98%

OMX Stockholm

-0.93%

Search another stock